• Home
  • MedDevices AI
  • Foxconn and NVIDIA: How Can AI-Driven Robotics Address the Projected 4.5 Million Nurse Shortage by 2030?
Image

Foxconn and NVIDIA: How Can AI-Driven Robotics Address the Projected 4.5 Million Nurse Shortage by 2030?

May 18, 2025

In response to the World Health Organization’s projection of a 4.5 million nurse shortage by 2030, Foxconn and NVIDIA have introduced “Nurabot,” an AI-powered collaborative nursing robot designed to alleviate the burden on healthcare professionals.

Strategic Deployment of Nurabot

Nurabot is currently being trialed in several Taiwanese hospitals, including Taichung Veterans General Hospital, Baishatun Tung Hospital – Mazu Hospital, and Cardinal Tien Hospital. These institutions are integrating Nurabot into their operations to enhance patient care and support nursing staff.

Technological Infrastructure

The development and deployment of Nurabot are supported by NVIDIA’s advanced AI technologies, including the NeMo framework and Hopper GPUs. These technologies enable Nurabot to perform tasks such as medication delivery, patient monitoring, and ward patrols.

Impact on Healthcare Operations

By automating routine tasks, Nurabot allows nursing staff to focus on more critical aspects of patient care, potentially improving overall hospital efficiency and patient outcomes.

Future Prospects

Looking ahead, the collaboration between Foxconn and NVIDIA aims to expand the capabilities of Nurabot, incorporating features like multilingual communication and advanced patient interaction, to further address the challenges posed by the impending nurse shortage.

For more information, visit the official NVIDIA blog.

Releated Posts

Prosper Medical’s $16M Raise Is a Bet That AI Can Make Concierge Medicine Affordable — Not Just Convenient

Analysis of Prosper Medical’s seed round, its AI-powered care model, and what it signals about the next phase…

ByByAnuja Singh Aug 3, 2026

The FDA Just Created a Reimbursement Pathway for AI-Driven Care — Here’s Why That Matters More Than the Device, Dexcom the first participant in its TEMPO pilot.

Analysis of the FDA’s TEMPO pilot, its first AI-enabled participant, and what it signals for how algorithmic health…

ByByAnuja Singh Aug 3, 2026

Can J&J’s Newly FDA-Approved Dual-Energy Ablation Catheter Help It Reclaim Ground Lost to Boston Scientific and Medtronic in PFA?

Key Highlights A Strategic Answer to Lost PFA Ground Johnson & Johnson enters the U.S. dual-energy ablation market…

ByByAnuja Singh Jul 16, 2026

Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital or Closed Data Experiment?

Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI agents across 300+…

ByByAnuja Singh Mar 4, 2026
Scroll to Top